Evidence review · standard
selank benzo withdrawal
Regeneration vs degeneration — where this fits
benzo withdrawal represents tissue breakdown exceeding repair capacity. Most interventions manage symptoms. This article examines whether selank mechanisms address underlying repair deficits.
What is known
Studied for anxiolytic pathways without classic benzodiazepine sedation.
Target condition: benzo withdrawal. Body system: GABA / CNS.
Logic chain
- selank studied for anxiolytic pathways without classic benzodiazepine sedation..
- benzo withdrawal involves gaba / cns dysfunction.
- If selank reaches the affected tissue, it may shift the repair/breakdown balance.
- This chain is tested in animal or lab models only.
Parent peptide claims relevant here
- In a 2008 randomized study of 62 patients with GAD and neurasthenia, Selank showed anxiolytic efficacy comparable to medazepam on psychometric scales without reported sedation, cognitive impairment, tolerance or withdrawal.
- Selank administration in rats alters expression of 45 neurotransmission-related genes at 1 hour and 22 genes at 3 hours, with positive correlation to GABA effects.
- Commercial vendors and clinics market this compound (7 commercial/clinic sources catalogued) — marketing material, not evidence.
- 2017 study showing Selank's anxiolytic effects comparable to benzodiazepines in rat stress model.
- 2019 rat study on Selank protecting against alcohol-related memory issues via BDNF regulation.
Evidence tier
Preclinical — animal and in vitro studies only. No published human trials for this specific combination.
What we do not know
- Whether selank reaches benzo withdrawal tissue at functional concentrations
- Optimal dosing, route, and duration for this target
- Interaction with standard-of-care treatments for benzo withdrawal
- Long-term safety profile in this population
Safety note
All peptide use for benzo withdrawal is research-context only. Not medical advice. Consult a physician before any experimental compound.
Key evidence
system
Combinatorial mapping (transparent): selank vs benzo-withdrawal — regen=0.717, degen=0.7, Δ=0.017. Method: layer_relevance(0.75) × evidence_factor(0.85); catalog.degen_score for Benzodiazepine withdrawal.
Model review1 contributions · 1 modelExpand the recursive review layer
1 / 1
Machine verification:
/api/articles/selank-benzo-withdrawal/contributionsAsk this article · 3 suggested prompts
Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.
What does the ledger say about this (system tier): "Combinatorial mapping (transparent): selank vs benzo-withdrawal — regen=0.717, degen=0.7, Δ=0.017. Method: layer_relevance(0.75) × evidence_…"?
ask selank-benzo-withdrawal claim c_map_selank-benzo-withdrawal · paste includes §SELF
What can you answer from your catalogue about selank benzo withdrawal — and what remains open or unverified?
ask selank-benzo-withdrawal gaps · paste includes §SELF
What are the strongest objections or counter-evidence on record against selank benzo withdrawal?
ask selank-benzo-withdrawal objections · paste includes §SELF